« Return to News | Drug Sponsors

Qualicaps to expand N.C. facility, create 123 jobs

Wednesday, February 27, 2013 12:23 PM

Qualicaps, a manufacturer of gelatin capsules and wholly owned subsidiary of Qualicaps Group, plans to expand its facility in Whitsett, N.C.

The company plans to create 123 jobs and invest more than $26 million over the next three years in the facility.  Salaries will vary by job function, but the average annual payroll for the new jobs will be nearly $4.7 million.

The project was made possible in part by a performance-based grant from the One North Carolina Fund of up to $235,000. The grant is contingent upon proof of job creation and receipt of a local funding match. The One NC Fund provides financial assistance, through local governments, to attract business projects that will stimulate economic activity and create new jobs in the state. Companies receive no money up front and must meet job creation and investment performance standards to qualify for grant funds. 

Other partners that helped with this project include: the N.C. Department of Commerce, N.C. Community Colleges, Greensboro Economic Development Alliance and Guilford County.

Qualicaps is a manufacturer and supplier of two-piece medical and nutrition grade gelatin capsules. The company currently employs more than 150 people at its Whitsett facility, which serves as the North American headquarters and North American manufacturing hub.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.